Related Experiment Videos
Inhibition of T and B lymphoblastic response by mithramycin, dacarbazine, prospidium chloride and peptichemio
Abstract:
Four different cytostatic compounds (prospidium chloride, peptichemio, dacarbazine and mithramycin) have been assayed for their effect on lymphoblastic transformation of spleen cells from mice. The drugs did not affect cell viability at concentrations lower than 0.1-0.2 micrograms/ml (peptichemio and mithramycin) or than 10-20 micrometers/ml (prospidium chloride and dacarbazine). Except for peptichemio, which did not show any marked effect, these cytostatics acted more actively on B cells than on T cells at concentrations of drug not affecting lymphocyte viability. Mithramycin was the most active inhibitor of the mitogen-induced DNA synthesis in the cell. Concentrations of this drug to inhibit the blastogenic response to 50% (IC50) were lower than 0.1 microgram/ml. Inhibition of mitogenesis was less pronounced in the case of dacarbazine (IC50 = 50 and 10 micrograms/ml for T and B cells, respectively), prospidium chloride (IC50 greater than 50 and 50 micrograms/ml for T and B cells) and peptichemio (IC50 = 0.25 and 0.5 microgram/ml for T and B cells, respectively.
Insights
Four cytostatic drugs were tested for their impact on mouse spleen cells. Mithramycin most effectively inhibited lymphocyte DNA synthesis, particularly in B cells, without harming cell viability.
Area of Science:
- Immunology
- Pharmacology
- Cell Biology
Background:
- Cytostatic compounds are crucial in cancer therapy.
- Understanding their differential effects on immune cells is vital for targeted drug development.
- Lymphocyte transformation assays provide insights into drug-induced immunomodulation.
Purpose of the Study:
- To evaluate the effects of four cytostatic drugs (prospidium chloride, peptichemio, dacarbazine, and mithramycin) on mouse spleen lymphocyte transformation.
- To determine the selectivity of these drugs towards T cells versus B cells.
- To assess the impact of these drugs on mitogen-induced DNA synthesis.
Main Methods:
- Assaying four cytostatic compounds on mouse spleen cells.
- Determining drug concentrations that do not affect cell viability.
- Measuring the inhibition of mitogen-induced DNA synthesis (mitogenesis) in T and B lymphocytes.
- Calculating IC50 values for each drug's effect on blastogenic response.
Main Results:
- Mithramycin demonstrated the highest inhibitory activity on DNA synthesis (IC50 < 0.1 microgram/ml).
- Dacarbazine, prospidium chloride, and peptichemio showed varying degrees of inhibition, with generally greater effects on B cells than T cells.
- Peptichemio exhibited minimal effect on lymphocyte transformation.
- Drug viability thresholds were established for each compound.
Conclusions:
- Mithramycin is a potent inhibitor of lymphocyte mitogenesis, with notable B-cell selectivity.
- The cytostatic drugs tested exhibit differential effects on T and B lymphocytes.
- These findings contribute to understanding the immunomodulatory potential of cytostatic agents.